Warning: The NCBI web site requires JavaScript to function. more...
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Fulford LG, Reis-Filho JS, Ryder K, Jones C, Gillett CE, Hanby A, Easton D, Lakhani SR.
Breast Cancer Res. 2007;9(1):R4.
Related citations
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO.
J Pathol. 2006 Mar;208(4):495-506.
Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomes.
Jones C, Ford E, Gillett C, Ryder K, Merrett S, Reis-Filho JS, Fulford LG, Hanby A, Lakhani SR.
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5988-97.
Cytokeratin profiles of male breast cancers.
Ciocca V, Bombonati A, Gatalica Z, Di Pasquale M, Milos A, Ruiz-Orrico A, Dreher D, Folch N, Monzon F, Santeusanio G, Perou CM, Bernard PS, Palazzo JP.
Histopathology. 2006 Oct;49(4):365-70.
[Basal and myoepithelial phenotype of metastatic mammary carcinomas. A prognostic factor in the palliative situation?].
Mainka P, Kahlert S, Kirchner T, Mayr D, Diebold J.
Pathologe. 2008 Nov;29 Suppl 2:363-9. German.
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.
Jumppanen M, Gruvberger-Saal S, Kauraniemi P, Tanner M, Bendahl PO, Lundin M, Krogh M, Kataja P, Borg A, Fernö M, Isola J.
Breast Cancer Res. 2007;9(1):R16.
The influence of basal phenotype on the metastatic pattern of breast cancer.
Luck AA, Evans AJ, Green AR, Rakha EA, Paish C, Ellis IO.
Clin Oncol (R Coll Radiol). 2008 Feb;20(1):40-5. Epub 2007 Nov 5.
Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile.
Dabbs DJ, Chivukula M, Carter G, Bhargava R.
Mod Pathol. 2006 Nov;19(11):1506-11. Epub 2006 Aug 25.
Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific type.
Hamilton LJ, Evans AJ, Pinder SE, James JJ, Gutteridge E, Cornford EJ, Burrell HC, Chan SY, Robertson JF, Cheung KL.
Clin Oncol (R Coll Radiol). 2004 Apr;16(2):119-24.
Basal-like breast carcinomas: clinical outcome and response to chemotherapy.
Banerjee S, Reis-Filho JS, Ashley S, Steele D, Ashworth A, Lakhani SR, Smith IE.
J Clin Pathol. 2006 Jul;59(7):729-35. Epub 2006 Mar 23.
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H, Rakha EA, Ball GR, Spiteri I, Aleskandarany M, Paish EC, Powe DG, Macmillan RD, Caldas C, Ellis IO, Green AR.
Breast Cancer Res Treat. 2010 May;121(1):41-51. Epub 2009 Jul 10.
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
Fulford LG, Easton DF, Reis-Filho JS, Sofronis A, Gillett CE, Lakhani SR, Hanby A.
Histopathology. 2006 Jul;49(1):22-34.
CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.
Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR.
Br J Cancer. 2001 Aug 3;85(3):422-7.
Epidermal growth factor receptor (EGFR) as a prognostic marker: an immunohistochemical study on 315 consecutive breast carcinoma patients.
Aziz SA, Pervez S, Khan S, Kayani N, Rahbar MH.
J Pak Med Assoc. 2002 Mar;52(3):104-10.
Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO.
Eur J Cancer. 2006 Dec;42(18):3149-56. Epub 2006 Oct 19.
[Basal-like breast cancers: clinicopathological features and outcome].
De Brot M, Soares FA, Stiepcich MM, Cúrcio VS, Gobbi H.
Rev Assoc Med Bras. 2009 Sep-Oct;55(5):529-34. Portuguese.
The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
Fadare O, Wang SA, Hileeto D.
Hum Pathol. 2008 Mar;39(3):331-6.
Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
Liu H, Fan Q, Zhang Z, Li X, Yu H, Meng F.
Hum Pathol. 2008 Feb;39(2):167-74. Epub 2007 Nov 28.
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.
Rakha EA, Gill MS, El-Sayed ME, Khan MM, Hodi Z, Blamey RW, Evans AJ, Lee AH, Ellis IO.
Breast Cancer Res Treat. 2009 Mar;114(2):243-50. Epub 2008 Apr 11.
Extracellular matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer: a Hospital-based Cohort Study in Iowa.
Lal G, Hashimi S, Smith BJ, Lynch CF, Zhang L, Robinson RA, Weigel RJ.
Ann Surg Oncol. 2009 Aug;16(8):2280-7. Epub 2009 Jun 12.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on